Inotuzumab (Anti-Siglec-2 / CD22)

Ask supplier a question | View on supplier's website

Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD.

Supplier	Selleck Chemicals
Product #	A2358
Sku #	A2358-1mg*25
Pricing	1mg*25, $2970.00

Feedback